Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma Efficacy of ...

An international expert consensus offers guidance to diagnose, assess, and treat adult patients experiencing drug reaction with eosinophilia and systemic symptoms (DRESS). Data on the evaluation, ...

Radiocontrast media play a pivotal role in diagnostic imaging; however, their administration is not without risk. Hypersensitivity reactions, which can range from mild skin eruptions to severe ...

Hypersensitivity reactions induced by proton pump inhibitors (PPIs) represent a growing concern given the extensive use of these agents for managing acid-related disorders. Although PPIs are generally ...

Please provide your email address to receive an email when new articles are posted on . 84.8% of patients who followed the protocol completed CT scans without any adverse reaction. 53.3% of patients ...

Please provide your email address to receive an email when new articles are posted on . An e-consult program for oncologists and allergy specialists had a mean turnaround time of 19.7 hours. Nine out ...

1 Department of Microbiology & Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia. An increasing number of HLA associations have been observed with drug-hypersensitivity ...

The American College of Radiology updated guidelines on intravenous iodinated construct media use and management of adverse reactions. ICM is widely used in the U.S.. However, there was a lack of ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...